---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-038054"
form_type: "8-K"
ticker: "HTCR"
cik: "0001892322"
company_name: "HeartCore Enterprises, Inc."
filed_at: "2024-09-25T23:59:59+00:00"
generated_at: "2026-05-31T01:55:28.986821+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# SBC Medical Group begins trading on Nasdaq; HeartCore guides Q3 rev $19-23M, net profit $4-8M

## Summary
- Go IPO client SBC Medical Group commenced trading on Nasdaq Global Market under symbol 'SBC'.
- HeartCore generated $17.9M total revenue from SBC deal; $17M recognized in Q3 2024.
- HeartCore holds $8M worth of SBC stock after IPO.
- Q3 2024 guidance: revenue $19M-$23M, net profit $4M-$8M.
- Sold $9M of warrants to a Japanese financial institution in Q1 2024; net sales $5.64M after referral fee.

## SEC filing metadata
- accession: 0001493152-24-038054
- form_type: 8-K
- ticker: HTCR
- cik: 0001892322
- company_name: HeartCore Enterprises, Inc.
- filed_at: 2024-09-25T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1892322/000149315224038054/0001493152-24-038054-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1892322/000149315224038054/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-038054
- JSON: https://secwatch.observer/filing/0001493152-24-038054.json
- Plain text: https://secwatch.observer/filing/0001493152-24-038054.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.